BioWorld

Oct. 29, 2007

View Archived Issues

Kosan, Roche End Partnership; Epothilone Goes Back Home

Kosan Biosciences Inc. and Roche Holding AG ended their five-year collaboration to develop and commercialize epothilones, anticancer agents that inhibit cell division. (BioWorld Today) Read More

Biotech Allozyne Improving Protein Drugs With $30M Round

Read More

Jennerex Seeks Oncolytic Strait Between Scylla And Charybdis

Read More

Clinical Data IVD Asset Sale: $19.5M For Drug, Test Bids

Read More

NovaBay Prices IPO At $4/Share Gets $20M To Advance Pipeline

Read More

Other News To Note

Read More

Clinic Roundup

Read More

Earnings Roundup

Read More

AACR Roundup

Read More